Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 20, 2011
The number of lymphoma-associated macrophages in tumor tissue is an independent prognostic factor in patients with follicular lymphomaBosko Andjelic, Biljana Mihaljevic, Milena Todorovic, et al.Medical Oncology (Northwood, London, England)|March 24, 2009
T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experienceAleksandra Sretenovic, Darko Antic, Snezana Jankovic, et al.European Journal of Haematology|May 7, 2014
A single institution experience on 314 newly diagnosed advanced Hodgkin lymphoma patients: the role of ABVD in daily practiceBosko Andjelic, Darko Antic, Ljubomir Jakovic, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|April 9, 2011
Simultaneous presentation of hairy cell leukemia and metastatic signet ring carcinoma of the stomach diagnosed by bone marrow biopsyMaja Perunicic-Jovanovic, Irena Djunic, Dragica Tomin, et al.International Journal of Hematology|December 26, 2008
Spinal epidural granulocytic sarcoma in non-leukemic patientDarko Antic, Srdan Verstovsek, Ivo Elezovic, et al.Medicina (Kaunas, Lithuania)|September 27, 2025
Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-RMarijana Virijevic, Ljubomir Jakovic, Lazar Trajkovic, et al.Medicina (Kaunas, Lithuania)|September 28, 2024
Early Prediction and Streamline of Nucleophosmin Mutation Status in Acute Myeloid Leukemia Using Cup-Like Nuclear MorphologyLjubomir Jakovic, Vesna Djordjevic, Nada Kraguljac Kurtovic, et al.Internal Medicine (Tokyo, Japan)|May 11, 2010
Isolated myeloid sarcoma of the gastrointestinal tractDarko Antic, Ivo Elezovic, Andrija Bogdanovic, et al.Leukemia Research|November 17, 2018
The predictive value of morphological findings in early diagnosis of acute myeloid leukemia with recurrent cytogenetic abnormalitiesLjubomir Jakovic, Andrija Bogdanovic, Vesna Djordjevic, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 28, 2015
BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypesMaja Perunicic Jovanovic, Biljana Mihaljevic, Ljubomir Jakovic, et al.Pageof 2